secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001213900-26-016519
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron appoints Stephen Willard as CEO; Powell resigns; 50% salary deferral enacted
--------------------------------------------------------------------------------

- Stephen H. Willard appointed permanent CEO effective Feb 11, 2026; succeeds interim CEO Than Powell who remains in BD role.
- Willard receives base salary $500K/yr, deferred to $250K during temporary 50% deferral period for CEO and Executive Chairman.
- Initial equity grant: 200K shares, 200K RSUs, 200K stock option; all vest quarterly over four years.
- Company implements cost reductions: 50% salary deferral for CEO/Exec Chairman, furloughs, reduced board fees; 50K RSUs to each exec.
- Pivotal Phase 2b HLHS trial top-line results expected Q3 2026; FDA guidance that success could support BLA filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/0001213900-26-016519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/ea0277101-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-016519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer